Alzamend Neuro, Inc.
ALZN · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,515 | -$9,948 | -$14,878 | -$12,362 |
| Dep. & Amort. | $51 | $51 | $23 | $4 |
| Deferred Tax | $0 | $0 | -$1,707 | $0 |
| Stock-Based Comp. | $325 | $956 | $3,583 | $4,409 |
| Change in WC | -$2,438 | $671 | $2,349 | $1,327 |
| Other Non-Cash | $9 | $1 | $1,707 | $9 |
| Operating Cash Flow | -$6,568 | -$8,270 | -$8,923 | -$6,614 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$300 | -$147 | $0 | -$106 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $5,375 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$5,375 |
| Investing Cash Flow | -$300 | -$147 | $0 | -$106 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $300 | $0 | $0 |
| Stock Issued | $2,704 | $1,252 | $989 | $18,911 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7,737 | $2,100 | $0 | $18,855 |
| Financing Cash Flow | $10,441 | $3,652 | $0 | $18,855 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3,573 | -$4,765 | -$8,923 | $12,135 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $376 | $5,141 | $14,064 | $1,929 |
| End Cash | $3,949 | $376 | $5,141 | $14,064 |
| Free Cash Flow | -$6,868 | -$8,417 | -$8,923 | -$6,720 |